PubMed:23537957 / 153-430
Annnotations
PubMed_ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-277 | DRI_Approach | denotes | The genomic sequences of low and high passages of the United States infectious laryngotracheitis (ILT) vaccine strains CEO and TCO were determined using hybrid next generation sequencing in order to define genomic changes associated with attenuation and reversion to virulence. |
Goldhamster2_Cellosaurus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 98-101 | CVCL_F909|Transformed_cell_line|Homo sapiens | denotes | ILT |
T3 | 127-130 | CVCL_HE32|Cancer_cell_line|Homo sapiens | denotes | TCO |
T4 | 214-221 | CVCL_0238|Cancer_cell_line|Homo sapiens | denotes | changes |
GoldHamster
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T13 | 111-118 | D013180 | denotes | strains |
T14 | 111-118 | D013180 | denotes | strains |
T15 | 119-122 | PR:A5HZ59 | denotes | CEO |
T17 | 127-130 | CVCL_HE32 | denotes | TCO |
T16 | 127-130 | CHEBI:73156 | denotes | TCO |
T18 | 127-130 | C537842 | denotes | TCO |
T19 | 153-159 | 37965 | denotes | hybrid |
T20 | 153-159 | D002678 | denotes | hybrid |
T21 | 267-276 | GO:0009405 | denotes | virulence |
T22 | 267-276 | GO:0009406 | denotes | virulence |
T23 | 267-276 | GO:0016032 | denotes | virulence |
Allie
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
SS1_23537957_1_0 | 68-96 | expanded | denotes | infectious laryngotracheitis |
SS2_23537957_1_0 | 98-101 | abbr | denotes | ILT |
AE1_23537957_1_0 | SS1_23537957_1_0 | SS2_23537957_1_0 | abbreviatedTo | infectious laryngotracheitis,ILT |